Signaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation

• Published in: Tissue engineering. Part B, Reviews Vol. 21; no. 4; pp. 377 - 392
• Main Authors: Parikh, Abhirath, Wu, Jincheng, Blanton, Robert M., Tzanakakis, Emmanuel S.
• Format: Journal Article
• Language: English
• Published: United States Mary Ann Liebert, Inc 01.08.2015
• Subjects: Animals; Cardiomyocytes; Cell Differentiation - genetics; Gene Regulatory Networks; Heart; Heart - embryology; Humans; Myocytes, Cardiac - cytology; Myocytes, Cardiac - metabolism; Pluripotent Stem Cells - cytology; Signal transduction; Signal Transduction - genetics; Stem cells; Tissue engineering
• ISSN: 1937-3368; 1937-3376; 1937-3376
• DOI: 10.1089/ten.teb.2014.0662

Strategies for harnessing stem cells as a source to treat cell loss in heart disease are the subject of intense research. Human pluripotent stem cells (hPSCs) can be expanded extensively in vitro and therefore can potentially provide sufficient quantities of patient-specific differentiated cardiomyocytes. Although multiple stimuli direct heart development, the differentiation process is driven in large part by signaling activity. The engineering of hPSCs to heart cell progeny has extensively relied on establishing proper combinations of soluble signals, which target genetic programs thereby inducing cardiomyocyte specification. Pertinent differentiation strategies have relied as a template on the development of embryonic heart in multiple model organisms. Here, information on the regulation of cardiomyocyte development from in vivo genetic and embryological studies is critically reviewed. A fresh interpretation is provided of in vivo and in vitro data on signaling pathways and gene regulatory networks (GRNs) underlying cardiopoiesis. The state-of-the-art understanding of signaling pathways and GRNs presented here can inform the design and optimization of methods for the engineering of tissues for heart therapies.